Brittle Cornea Syndrome 2, also known as bcs2, is related to brittle cornea syndrome and brittle cornea syndrome 1, and has symptoms including unspecified visual loss An important gene associated with Brittle Cornea Syndrome 2 is PRDM5 (PR/SET Domain 5), and among its related pathways/superpathways is Disorders of transmembrane transporters. The drugs Riboflavin and Folic acid have been mentioned in the context of this disorder. Affiliated tissues include skin and eye, and related phenotypes are flat cornea and hearing impairment